859 related articles for article (PubMed ID: 19703341)
1. Analysis of solid-state transformations of pharmaceutical compounds using vibrational spectroscopy.
Heinz A; Strachan CJ; Gordon KC; Rades T
J Pharm Pharmacol; 2009 Aug; 61(8):971-88. PubMed ID: 19703341
[TBL] [Abstract][Full Text] [Related]
2. Perspectives in the use of spectroscopy to characterise pharmaceutical solids.
Aaltonen J; Gordon KC; Strachan CJ; Rades T
Int J Pharm; 2008 Dec; 364(2):159-69. PubMed ID: 18555625
[TBL] [Abstract][Full Text] [Related]
3. Understanding the solid-state forms of fenofibrate--a spectroscopic and computational study.
Heinz A; Gordon KC; McGoverin CM; Rades T; Strachan CJ
Eur J Pharm Biopharm; 2009 Jan; 71(1):100-8. PubMed ID: 18590814
[TBL] [Abstract][Full Text] [Related]
4. Raman spectroscopy for quantitative analysis of pharmaceutical solids.
Strachan CJ; Rades T; Gordon KC; Rantanen J
J Pharm Pharmacol; 2007 Feb; 59(2):179-92. PubMed ID: 17270072
[TBL] [Abstract][Full Text] [Related]
5. Quantifying ternary mixtures of different solid-state forms of indomethacin by Raman and near-infrared spectroscopy.
Heinz A; Savolainen M; Rades T; Strachan CJ
Eur J Pharm Sci; 2007 Nov; 32(3):182-92. PubMed ID: 17716878
[TBL] [Abstract][Full Text] [Related]
6. Terahertz pulsed spectroscopy and imaging in the pharmaceutical setting--a review.
Zeitler JA; Taday PF; Newnham DA; Pepper M; Gordon KC; Rades T
J Pharm Pharmacol; 2007 Feb; 59(2):209-23. PubMed ID: 17270075
[TBL] [Abstract][Full Text] [Related]
7. Better understanding of dissolution behaviour of amorphous drugs by in situ solid-state analysis using Raman spectroscopy.
Savolainen M; Kogermann K; Heinz A; Aaltonen J; Peltonen L; Strachan C; Yliruusi J
Eur J Pharm Biopharm; 2009 Jan; 71(1):71-9. PubMed ID: 18590816
[TBL] [Abstract][Full Text] [Related]
8. Terahertz pulsed spectroscopy and imaging for pharmaceutical applications: a review.
Shen YC
Int J Pharm; 2011 Sep; 417(1-2):48-60. PubMed ID: 21237260
[TBL] [Abstract][Full Text] [Related]
9. Near-infrared chemical imaging (NIR-CI) on pharmaceutical solid dosage forms-comparing common calibration approaches.
Ravn C; Skibsted E; Bro R
J Pharm Biomed Anal; 2008 Nov; 48(3):554-61. PubMed ID: 18774667
[TBL] [Abstract][Full Text] [Related]
10. [Crystalline modifications and polymorphism changes during drug manufacture].
Doelker E
Ann Pharm Fr; 2002 May; 60(3):161-76. PubMed ID: 12050595
[TBL] [Abstract][Full Text] [Related]
11. High-throughput crystallization: polymorphs, salts, co-crystals and solvates of pharmaceutical solids.
Morissette SL; Almarsson O; Peterson ML; Remenar JF; Read MJ; Lemmo AV; Ellis S; Cima MJ; Gardner CR
Adv Drug Deliv Rev; 2004 Feb; 56(3):275-300. PubMed ID: 14962582
[TBL] [Abstract][Full Text] [Related]
12. [Pharmaceutical significance of amorphous materials].
Antal I; Zelkó R
Acta Pharm Hung; 2008; 78(3):121-33. PubMed ID: 18986089
[TBL] [Abstract][Full Text] [Related]
13. Solid state amorphization of pharmaceuticals.
Willart JF; Descamps M
Mol Pharm; 2008; 5(6):905-20. PubMed ID: 18954076
[TBL] [Abstract][Full Text] [Related]
14. Applications of NIR spectroscopy to monitoring and analyzing the solid state during industrial crystallization processes.
Févotte G; Calas J; Puel F; Hoff C
Int J Pharm; 2004 Apr; 273(1-2):159-69. PubMed ID: 15010140
[TBL] [Abstract][Full Text] [Related]
15. Drug hydrate systems and dehydration processes studied by terahertz pulsed spectroscopy.
Zeitler JA; Kogermann K; Rantanen J; Rades T; Taday PF; Pepper M; Aaltonen J; Strachan CJ
Int J Pharm; 2007 Apr; 334(1-2):78-84. PubMed ID: 17129691
[TBL] [Abstract][Full Text] [Related]
16. Characterization of pharmaceutically relevant materials at the solid state employing chemometrics methods.
Calvo NL; Maggio RM; Kaufman TS
J Pharm Biomed Anal; 2018 Jan; 147():538-564. PubMed ID: 28666554
[TBL] [Abstract][Full Text] [Related]
17. Understanding the solid-state behaviour of triglyceride solid lipid extrudates and its influence on dissolution.
Windbergs M; Strachan CJ; Kleinebudde P
Eur J Pharm Biopharm; 2009 Jan; 71(1):80-7. PubMed ID: 18588976
[TBL] [Abstract][Full Text] [Related]
18. [Advances in the quantitative analytical methods of drug polymorphism].
Ma LW; Du W; Zhao CS
Yao Xue Xue Bao; 2011 Aug; 46(8):896-903. PubMed ID: 22007512
[TBL] [Abstract][Full Text] [Related]
19. Quantifying low levels of polymorphic impurity in clopidogrel bisulphate by vibrational spectroscopy and chemometrics.
Német Z; Demeter A; Pokol G
J Pharm Biomed Anal; 2009 Jan; 49(1):32-41. PubMed ID: 19019611
[TBL] [Abstract][Full Text] [Related]
20. Applications of solid-state NMR to pharmaceutical polymorphism and related matters.
Harris RK
J Pharm Pharmacol; 2007 Feb; 59(2):225-39. PubMed ID: 17270076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
